Abstract
Introduction Latent toxoplasmosis, affecting approximately one-third of people worldwide, was once thought to be asymptomatic. However, studies in the last three decades have revealed that it can cause significant psychological and behavioral changes in humans. The observation that the behavioral impacts of toxoplasmosis manifest in opposite directions in men and women has led to the development of the Stress-Coping Hypothesis. This hypothesis posits that health degradation from toxoplasmosis results in chronic stress, with gender-specific coping strategies explaining the divergent behavioral responses observed between men and women.
Methods This study, conducted on 1,768 individuals who had previously been tested for toxoplasmosis or borreliosis, sought to examine this hypothesis through a survey that included the Perceived Stress Scale and the State-Trait Anxiety Inventory.
Results Confirmed poorer health, higher stress, and anxiety levels among Toxoplasma-infected participants. Path analysis showed that toxoplasmosis directly negatively impacts physical health, which in turn directly increases stress and anxiety among infected individuals, thereby negatively affecting cognitive performance. This pattern was not seen with borreliosis, serving as a negative control, underscoring the unique impact of toxoplasmosis on human physical health, well-being, and cognition.
Conclusions Our findings strongly suggest that the cognitive impairments associated with toxoplasmosis are primarily side effects of chronic stress resulting from the compromised health of infected individuals.
Key Points Chronic stress mediates the negative effects of toxoplasmosis on cognition, stemming from the impaired health of infected individuals.
This effect was not observed with the negative control, borreliosis.
Our results support the side effects hypothesis and contradict the parasite manipulation hypothesis.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was supported by Czech Science Foundation, grant number 22-20785S.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the Institutional Review Board of the Faculty of Science, Charles University (No. 2020/25), and conducted in accordance with all relevant guidelines and regulations.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data are available at figshare https://doi.org/10.6084/m9.figshare.25188788.v1.
